Rome, Italy

Antonio Virdia

This inventor holds 1 USPTO granted patent. Top assignees: Eniricerche S.p.a., Polifarma S.p.a.. Active years: 1988.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Antonio Virdia: Innovator in Pharmacologically Active Tripeptides

Introduction

Antonio Virdia is a notable inventor based in Rome, Italy. He has made significant contributions to the field of pharmacology, particularly through his innovative work on tripeptides. His research focuses on the synthesis of pharmacologically active compounds that have potential therapeutic applications.

Latest Patents

Antonio Virdia holds a patent for "Pharmacologically active tripeptides and process for their synthesis." This patent describes pharmacologically active tripeptides characterized by at least a retro-inverted peptidic bond. The compounds are defined by specific general formulae and include their pharmaceutically acceptable salts, esters, or alkyl amides. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Throughout his career, Antonio has worked with prominent companies in the pharmaceutical sector. Notably, he has been associated with Eniricerche S.p.a. and Polifarma S.p.a., where he contributed to various research and development projects. His work has had a lasting impact on the field of pharmacology.

Collaborations

Antonio Virdia has collaborated with several professionals in his field, including Alessandro Sisto and Antonio S Verdini. These collaborations have enriched his research and expanded the scope of his innovative work.

Conclusion

Antonio Virdia is a distinguished inventor whose work on pharmacologically active tripeptides has advanced the field of pharmacology. His contributions through patents and collaborations highlight his commitment to innovation and research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…